<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Roche has acquired Bina Technologies !!!]]></title>
	<link>https://bioinformaticsonline.com/news/view/20007/roche-has-acquired-bina-technologies?</link>
	<atom:link href="https://bioinformaticsonline.com/news/view/20007/roche-has-acquired-bina-technologies?" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/20007/roche-has-acquired-bina-technologies</guid>
	<pubDate>Tue, 30 Dec 2014 09:42:16 -0600</pubDate>
	<link>https://bioinformaticsonline.com/news/view/20007/roche-has-acquired-bina-technologies</link>
	<title><![CDATA[Roche has acquired Bina Technologies !!!]]></title>
	<description><![CDATA[<p>Bina Technologies is a privately held company that provides a big data platform for centralized management and processing of next generation sequencing (NGS) data for the academic and translational research markets.&nbsp; Bina will be integrated into the Roche Sequencing Unit, and will continue to focus on development of their innovative genomic analysis solution.<br /><br />Roche has acquired Bina Technologies, a privately-owned biotech company based in California. The biotech&rsquo;s first product was the Bina Box, a platform for secondary genomic analysis, sequence alignment, and variant calling, but since 2012, it has developed other products and platforms. <br /><br />It is our shared vision with Roche that informatics and data sciences are critical elements of an end-to-end genomics solution. Fast, easy-to-use, scalable, and robust informatics solutions make a big difference in the quality and impact of the work of scientists and researchers. We believe in the future of data-driven, personalized medicine. We are passionate about accelerating that future together with Roche.<br /><br />Financial details of the deal were not disclosed. For Roche, the move is yet another in a string of acquisitions. Last week (December 18), Roche paid $489 million for antibody maker Dutalys. And earlier this month, Roche bought prenatal testing company Ariosa Diagnostics.</p><p>Reference</p><p>http://blog.bina.com/news/bina-technologies-acquired-by-roche?&amp;__hssc=109677338.1.1419953400266&amp;__hstc=109677338.b8350f2729889b08f1325906d5236cd3.1419953400266.1419953400266.1419953400266.1&amp;hsCtaTracking=96cac941-9372-4bbf-bacb-3ca6f1ff8cfd|3fce0f18-835b-4086-9345-388880861732</p><p>http://www.the-scientist.com/?articles.view/articleNo/41750/title/Roche-Buys-Bioinformatics-Firm/</p>]]></description>
	<dc:creator>Jit</dc:creator>
</item>

</channel>
</rss>